Medical Research
(H12)
990 on File
BIG TEN CANCER RESEARCH CONSORTIUM FOUNDATION INC
Financial strength (30%)
76/100
Reliability (20%)
50/100
Effectiveness (25%)
61/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$117K
Total Revenue
$13K
Total Expenses
$397K
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
100.0%
Fundraising Efficiency
N/A
Operating Reserve
354.98x
Liability-to-Asset
4.8%
Revenue Diversification
68.0%
Compared with Peers
FY 2025
Compared with 378 similar organizations
(United States, Medical Research, under $100K in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
100.0% | 75.9% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
355.0 mo | 44.2 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
4.8% | 0.0% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
68.0% | 100.0% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
3.8% | 2.1% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-85.2% | -2.5% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
88.5% | 20.0% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $117K | $13K | $397K | 100.0% | — |
| 2024 | $113K | $91K | $294K | 17.6% | — |
| 2023 | $182K | $65K | $272K | 22.7% | — |
| 2022 | $125K | $3K | $196K | 100.0% | — |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.